Private Market View

OpenEvidence

Miami, FL · Founded 2017 · Privately Held (backing)

PA Mark · $/share
$508
Sep 2026
Implied valuation
$12.1B
Total raised
$795.4M
Last round
Series A

Key facts

as of Sep 2026
  • OpenEvidence is valued at approximately $12.1B (~$508/share) as of Sep 2026, per Private Market View’s composite mark.
  • It has raised $795.4M across 9 recorded rounds; the latest was Later Stage VC ($250.0M) in Mar 2026.
  • Notable investors include Sequoia Capital, GV, Coatue Management, Greycroft, Kleiner Perkins — 39 tracked in total.
  • Private Market View tracks 6 recorded secondary trades in OpenEvidence shares.
  • 1 investment vehicle was formed to buy OpenEvidence shares in the last 12 months, reporting $5.8M sold to 79 investors, per SEC Form D filings.
  • Status: Privately Held (backing).
PA Mark — composite indicative price
LOW confidence
~$508per share
implies $12.1B valuation · as of Sep 2026 · the exact daily mark is a member feature
Composed from 6 inputs:3rd-party trades 93%Round prints 7%
See the platform prints behind this mark →
Free account
See the evidence behind this price
  • ·Post-money valuations for all 9 rounds
  • ·The complete investor list — 39 names
  • ·Watchlist + deal alerts for OpenEvidence
Create free account
No card required

Recorded secondary trades

6 on record · Mar 2026 – May 2026

6 trades between Mar 2026 and May 2026. Exact dates, prices and structures are available to Pro members.

Mar 2026peak 3 prints / monthMay 2026
Counts and months are public. The prints are the product.Unlock 6 trade prints

Institutional fund marks

No fund marks yet

No SEC-registered fund has reported a fair-value mark on OpenEvidence in its N-PORT filings yet. We sweep new filings monthly.

Pro members can request priority coverage with a 48-hour turnaround.

Funding rounds

9 rounds
Series A$3.4M▮
Mar 2026Series D$250.0M▮
Oct 2025Series C$200.0M▮
Jul 2025Series B$210.0M▮
Feb 2025Series A$75.0M▮
Full funding history →

Secondary demand: investment vehicles

from SEC Form D filings

In the last 12 months, 1 investment vehicle were formed to buy OpenEvidence shares, reporting $5.8M sold to 79 investors. Most recent filing Apr 2026. Vehicles like these are how secondary buyers pool demand for a name; a rising count is a demand signal.

The vehicle list — each sponsor, filing date, amount sold and investor count — is a Pro table. Unlock the 1 vehicle →
Companies with the most vehicle activity →

Leadership

About OpenEvidence

Developer of an AI-powered information platform designed to organize medical knowledge and make it useful, accessible, and understandable. The company's platform offers a curated database of journal content, advanced medical AI search, and patient documentation tools to make more evidence-based decisions and improve patient outcomes, enabling healthcare professionals to access relevant research and promote care decision-making.

Sector
Healthcare
HQ
Miami, FL, United States
Founded
2017
Employees
36
Ownership
Privately Held (backing)